Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Selecta Biosciences stock | $4.27

Learn how to easily invest in Selecta Biosciences stock.

Selecta Biosciences Inc is a biotechnology business based in the US. Selecta Biosciences shares (SELB) are listed on the NASDAQ and all prices are listed in US Dollars. Selecta Biosciences employs 43 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Selecta Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SELB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Selecta Biosciences stock price (NASDAQ: SELB)

Use our graph to track the performance of SELB stocks over time.

Selecta Biosciences shares at a glance

Information last updated 2021-10-17.
Latest market close$4.27
52-week range$2.17 - $5.70
50-day moving average $4.32
200-day moving average $4.02
Wall St. target price$8.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.41

Buy Selecta Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Selecta Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Selecta Biosciences price performance over time

Historical closes compared with the close of $4.27 from 2021-10-15

1 week (2021-10-12) -1.61%
1 month (2021-09-17) -4.04%
3 months (2021-07-19) 16.99%
6 months (2021-04-19) 12.07%
1 year (2020-10-19) 87.28%
2 years (2019-10-18) 200.70%
3 years (2018-10-19) 13.81
5 years (2016-10-19) 17.36

Selecta Biosciences financials

Revenue TTM $47.3 million
Gross profit TTM $-37,908,000
Return on assets TTM -13.85%
Return on equity TTM 0%
Profit margin -95.56%
Book value $0.10
Market capitalisation $491.4 million

TTM: trailing 12 months

Shorting Selecta Biosciences shares

There are currently 7.3 million Selecta Biosciences shares held short by investors – that's known as Selecta Biosciences's "short interest". This figure is 9.7% up from 6.6 million last month.

There are a few different ways that this level of interest in shorting Selecta Biosciences shares can be evaluated.

Selecta Biosciences's "short interest ratio" (SIR)

Selecta Biosciences's "short interest ratio" (SIR) is the quantity of Selecta Biosciences shares currently shorted divided by the average quantity of Selecta Biosciences shares traded daily (recently around 918616.49874055). Selecta Biosciences's SIR currently stands at 7.94. In other words for every 100,000 Selecta Biosciences shares traded daily on the market, roughly 7940 shares are currently held short.

However Selecta Biosciences's short interest can also be evaluated against the total number of Selecta Biosciences shares, or, against the total number of tradable Selecta Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Selecta Biosciences's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Selecta Biosciences shares in existence, roughly 60 shares are currently held short) or 0.0888% of the tradable shares (for every 100,000 tradable Selecta Biosciences shares, roughly 89 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Selecta Biosciences.

Find out more about how you can short Selecta Biosciences stock.

Selecta Biosciences share dividends

We're not expecting Selecta Biosciences to pay a dividend over the next 12 months.

Selecta Biosciences share price volatility

Over the last 12 months, Selecta Biosciences's shares have ranged in value from as little as $2.17 up to $5.7. A popular way to gauge a stock's volatility is its "beta".

SELB.US volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Selecta Biosciences's is 1.0291. This would suggest that Selecta Biosciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Selecta Biosciences overview

Selecta Biosciences, Inc. , a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's proprietary pipeline includes enzymes therapies, gene therapies, and other products and product candidates affected by undesired immune responses. Its lead product is SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout, as well as develops a product candidate to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and IgA vasculitis. The company also engages in the development of gene therapy product candidates that are in preclinical development, including MMA-101, a product candidate for the treatment methylmalonic academia; SEL-313, a product candidate to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to indicate appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and other products for the treatment of pompe disease, duchenne muscular dystrophy, and limb-girdle muscular dystrophy. In addition, it develops a product candidate to treat primary biliary cholangitis. The company has license and collaboration agreements with Swedish Orphan Biovitrum; Spark Therapeutics; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co.

Frequently asked questions

What percentage of Selecta Biosciences is owned by insiders or institutions?
Currently 28.448% of Selecta Biosciences shares are held by insiders and 47.024% by institutions.
How many people work for Selecta Biosciences?
Latest data suggests 43 work at Selecta Biosciences.
When does the fiscal year end for Selecta Biosciences?
Selecta Biosciences's fiscal year ends in December.
Where is Selecta Biosciences based?
Selecta Biosciences's address is: 65 Grove Street, Watertown, MA, United States, 02472
What is Selecta Biosciences's ISIN number?
Selecta Biosciences's international securities identification number is: US8162121045
What is Selecta Biosciences's CUSIP number?
Selecta Biosciences's Committee on Uniform Securities Identification Procedures number is: 816212104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site